Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression

Citations Over TimeTop 10% of 2024 papers

Abstract

The two types of craniopharyngioma, adamantinomatous (ACP) and papillary (PCP), are clinically relevant tumours in children and adults. Although the biology of primary craniopharyngioma is starting to be unravelled, little is known about the biology of recurrence. To fill this gap in knowledge, we have analysed through methylation array, RNA sequencing and pERK1/2 immunohistochemistry a cohort of paired primary and recurrent samples (32 samples from 14 cases of ACP and 4 cases of PCP). We show the presence of copy number alterations and clonal evolution across recurrence in 6 cases of ACP, and analysis of additional whole genome sequencing data from the Children's Brain Tumour Network confirms chromosomal arm copy number changes in at least 7/67 ACP cases. The activation of the MAPK/ERK pathway, a feature previously shown in primary ACP, is observed in all but one recurrent cases of ACP. The only ACP without MAPK activation is an aggressive case of recurrent malignant human craniopharyngioma harbouring a CTNNB1 mutation and loss of TP53. Providing support for a functional role of this TP53 mutation, we show that Trp53 loss in a murine model of ACP results in aggressive tumours and reduced mouse survival. Finally, we characterise the tumour immune infiltrate showing differences in the cellular composition and spatial distribution between ACP and PCP. Together, these analyses have revealed novel insights into recurrent craniopharyngioma and provided preclinical evidence supporting the evaluation of MAPK pathway inhibitors and immunomodulatory approaches in clinical trials in against recurrent ACP.

Related Papers

• → ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy(2018)63 cited
• → Endogenous, regulatory cysteine sulfenylation of ERK kinases in response to proliferative signals(2017)33 cited
• → The future of neurology after the COVID-19 pandemic according to neurology residents(2022)5 cited
• DMP1's signal pathway via MAPK-ERK(2013)
• 探討與MAPK/ERK訊息傳遞相關之新穎微型RNA在訊息傳遞之調控及對黑色素瘤的作用;Exploration of Novel MAPK/ERK Related Micrornas in Regulation of MAPK/ERK Signaling Pathway and Their Functional Effects in Melanoma(2016)